SCOPUS 정보 검색 플랫폼

Pathology and Oncology Research

Volumn 15, Issue 3, 2009, Pages 383-387

Short or long survival in multiple myeloma. A simple method for determining the prognosis

(5) Várkonyi, Judit a Bajzik, Edina a Fazakas, Ádám a Sipka, Sándor b Karádi, István a

a SEMMELWEIS UNIVERSITY OF MEDICINE (Hungary)

b UNIVERSITY OF DEBRECEN (Hungary)

Author keywords

AMWBC score; Multiple myeloma; Prognostic factors

Indexed keywords

ALBUMIN; GRANULOCYTE ANTIBODY;

ADULT; AGED; ALBUMINURIA; ARTICLE; CANCER INFILTRATION; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 73449112979 PISSN: 12194956 EISSN: None Source Type: Journal
DOI: 10.1007/s12253-008-9134-9 Document Type: Article

Times cited : (2)

References (17)

1
- 8944220233
- A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
- DOI 10.1056/NEJM199607113350204
- M Attal JL Harorusseau AM Stoppa, et al. 1996 A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma NEJM 335 9 7 10.1056/NEJM199607113350204 (Pubitemid 26240110)
- (1996) New England Journal of Medicine , vol.335 , Issue.2 , pp. 91-97
- Attal, M.¹ Harousseau, J.-L.² Stoppa, A.-M.³ Sotto, J.-J.⁴ Fuzibet, J.-G.⁵ Rossi, J.-F.⁶ Casassus, P.⁷ Maisonneuve, H.⁸ Facon, T.⁹ Ifrah, N.¹⁰ Payen, C.¹¹ Bataille, R.¹²

2
- 0020656085
- Long term survival in multiple myeloma
- 1:STN:280:DyaL3s7hsFWjtQ%3D%3D 6823231
- RA Kyle 1983 Long term survival in multiple myeloma NEJM 308 314 316 1:STN:280:DyaL3s7hsFWjtQ%3D%3D 6823231
- (1983) NEJM , vol.308 , pp. 314-316
- Kyle, R.A.¹

3
- 0016804136
- A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival
- 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U
- BGM Durie SE Salmon 1975 A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival Cancer 38 842 854 10.1002/1097-0142(197509) 36:3<842::AID-CNCR2820360303>3.0.CO;2-U
- (1975) Cancer , vol.38 , pp. 842-854
- Durie, B.G.M.¹ Salmon, S.E.²

4
- 0022360010
- Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1)
- DOI 10.1002/ajh.2830200311
- PR Greipp TE Witzig NJ Gonchoroff 1985 Immunofluorescent plasma cell labeling indices (Li) using a monoclonal antibody (Bu-1) Am J Hematol 20 289 10.1002/ajh.2830200311 1:STN:280:DyaL28%2Fkslyjtw%3D%3D 3904417 (Pubitemid 16248073)
- (1985) American Journal of Hematology , vol.20 , Issue.3 , pp. 289-292
- Greipp, P.R.¹ Witzig, T.E.² Gonchoroff, N.J.³

5
- 0024214068
- The antigen/receptor specificity of antigegranulocyte antibodies in patients with SLE
- 10.1016/0165-2478(88)90163-0
- A Sipos C Csortos S Sipka, et al. 1998 The antigen/receptor specificity of antigegranulocyte antibodies in patients with SLE Immunol Letters 19 329 334 10.1016/0165-2478(88)90163-0
- (1998) Immunol Letters , vol.19 , pp. 329-334
- Sipos, A.¹ Csortos, C.² Sipka, S.³

6
- 0034051068
- Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
- DOI 10.1146/annurev.med.51.1.245
- WB Ershler ET Keller 2000 Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty Annu Rev Med 51 245 270 10.1146/annurev.med.51.1.245 1:CAS:528:DC%2BD3cXisVelsbY%3D 10774463 (Pubitemid 30216036)
- (2000) Annual Review of Medicine , vol.51 , pp. 245-270
- Ershler, W.B.¹ Keller, E.T.²

7
- 73449131874
- Prognostic factors in survival for patients with multiple myeloma from a single institution over 30 years
- /10S1/A 4089
- Gautier M, Robertson J, Hars V (1997) Prognostic factors in survival for patients with multiple myeloma from a single institution over 30 years. Blood 90:/10S1/A 4089
- (1997) Blood , vol.90
- Gautier, M.¹ Robertson, J.² Hars, V.³

8
- 18544363372
- Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma
- DOI 10.1046/j.1365-2141.2002.03757.x
- ABT Fassa T Spencer J Sawyer, et al. 2002 Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma Brit J Haematol 118 1041 1047 10.1046/j.1365-2141.2002.03757.x (Pubitemid 35025967)
- (2002) British Journal of Haematology , vol.118 , Issue.4 , pp. 1041-1047
- Fassas, A.B.-T.¹ Spencer, T.² Sawyer, J.³ Zangari, M.⁴ Lee, C.-K.⁵ Anaissie, E.⁶ Muwalla, F.⁷ Morris, C.⁸ Barlogie, B.⁹ Tricot, G.¹⁰

9
- 0042128635
- A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience
- DOI 10.1046/j.1365-2141.2003.04456.x
- JL Jacobson MA Hussein B Barlogie, et al. 2003 A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience Brit J Haematol 122 441 450 10.1046/j.1365-2141.2003.04456.x (Pubitemid 36951628)
- (2003) British Journal of Haematology , vol.122 , Issue.3 , pp. 441-450
- Jacobson, J.L.¹ Hussein, M.A.² Barlogie, B.³ Durie, B.G.M.⁴ Crowley, J.J.⁵

10
- 0024458105
- A new prognostic system for multiple myeloma based on easily available parameters
- 10.1111/j.1365-2141.1989.tb04314.x
- J Bladé C Rozman F Cervantes, et al. 1989 A new prognostic system for multiple myeloma based on easily available parameters Brit J Haematol 72 507 511 10.1111/j.1365-2141.1989.tb04314.x
- (1989) Brit J Haematol , vol.72 , pp. 507-511
- Bladé, J.¹ Rozman, C.² Cervantes, F.³

11
- 0036020963
- Determination of plasma cell secreting potential as an index of maturity of myelomatous cells and a strong prognostic factor
- DOI 10.1080/1042819021000002938
- A Symeonidis A Kouraklis-Symeonidis E Grouzi, et al. 2002 Determination of Plasma cell screening potential as an index of maturity myelomatous cell and a strong prognostic factor Leukemia Lymphoma 43 1605 1612 10.1080/ 1042819021000002938 1:STN:280:DC%2BD38nktFamsA%3D%3D 12400603 (Pubitemid 34823481)
- (2002) Leukemia and Lymphoma , vol.43 , Issue.8 , pp. 1605-1612
- Symeonidis, A.¹ Kouraklis-Symeonidis, A.² Grouzi, E.³ Zolota, V.⁴ Melachrinou, M.⁵ Kourea, K.⁶ Fragopanagou, E.⁷ Giannakoulas, N.⁸ Seimeni, U.⁹ Tiniakou, M.¹⁰ Matsouka, P.¹¹ Zoumbos, N.¹²

12
- 0037216353
- Review of 1,027 patients with newly diagnosed multiple myeloma
- 10.4065/78.1.21 12528874
- RA Kyle MA Gertz TE Witzig, et al. 2003 Review of 1,027 patients with newly diagnosed multiple myeloma Mayo Clin Proc 78 21 33 10.4065/78.1.21 12528874
- (2003) Mayo Clin Proc , vol.78 , pp. 21-33
- Kyle, R.A.¹ Gertz, M.A.² Witzig, T.E.³

13
- 20644460600
- International staging system for multiple myeloma
- DOI 10.1200/JCO.2005.04.242
- PR Greipp JS Miguel BGM Durie, et al. 2005 International staging system for multiple myeloma JCO 23 3412 3420 10.1200/JCO.2005.04.242 (Pubitemid 46243484)
- (2005) Journal of Clinical Oncology , vol.23 , Issue.15 , pp. 3412-3420
- Greipp, P.R.¹ Miguel, J.S.² Dune, B.G.M.³ Crowley, J.J.⁴ Barlogie, B.⁵ Blade, J.⁶ Boccadoro, M.⁷ Child, J.A.⁸ Harousseau, J.-L.⁹ Kyle, R.A.¹⁰ Lahuerta, J.J.¹¹ Ludwig, H.¹² Morgan, G.¹³ Powles, R.¹⁴ Shimizu, K.¹⁵ Shustik, C.¹⁶ Sonneveld, P.¹⁷ Tosi, P.¹⁸ Turesson, I.¹⁹ Westin, J.²⁰ more..

14
- 0026859218
- The significance of myelodysplasia in untreated patients with multiple myeloma
- 1:STN:280:DyaK38zjtlOltg%3D%3D
- M Mori T Abe T Takei, et al. 1992 The significance of myelodysplasia in untreated patients with multiple myeloma Rhinosho-Keutsueki 33 662 665 1:STN:280:DyaK38zjtlOltg%3D%3D
- (1992) Rhinosho-Keutsueki , vol.33 , pp. 662-665
- Mori, M.¹ Abe, T.² Takei, T.³

15
- 0022619224
- Immunological abnormalities in myelodysplastic syndromes
- 10.1111/j.1365-2141.1986.tb07505.x
- JA Coppelstone GJ Mufti TJ Hamblin, et al. 1986 Immunological abnormalities in myelodysplastic syndromes Brit J Haematol 63 149 159 10.1111/j.1365-2141.1986.tb07505.x
- (1986) Brit J Haematol , vol.63 , pp. 149-159
- Coppelstone, J.A.¹ Mufti, G.J.² Hamblin, T.J.³

16
- 19944428373
- An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma
- DOI 10.1038/sj.bjc.6602225
- I Hus A Dmoszynska J Manko, et al. 2004 An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma Brit J Cancer 91 1873 1879 10.1038/sj.bjc.6602225 1:CAS:528:DC%2BD2cXhtVSqs7nP 15520820 (Pubitemid 40065514)
- (2004) British Journal of Cancer , vol.91 , Issue.11 , pp. 1873-1879
- Hus, I.¹ Dmoszynska, A.² Manko, J.³ Hus, M.⁴ Jawniak, D.⁵ Soroka-Wojtaszko, M.⁶ Hellmann, A.⁷ Ciepluch, H.⁸ Skotnicki, A.⁹ Wolska-Smolen, T.¹⁰ Sulek, K.¹¹ Robak, T.¹² Konopka, L.¹³ Kloczko, J.¹⁴

17
- 73449098930
- The international prognostic index (IPI) is predictive for survival in refractory or relapsed myeloma patients treated with thalidomide-based regimens
- A Anagnostopoulos K Zervas A Zomas, et al. 2003 The international prognostic index (IPI) is predictive for survival in refractory or relapsed myeloma patients treated with thalidomide-based regimens Blood 937A 3492
- (2003) Blood , vol.937 , pp. 3492
- Anagnostopoulos, A.¹ Zervas, K.² Zomas, A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.